专题报道 |
|
|
|
|
甲状腺微小乳头状癌患者颈部中央淋巴结清扫术后假阴性风险概率的评估 |
刘文,董治中,苏艳军,马云海,张建明,刁畅,钱军,程若川( ) |
昆明医科大学第一附属医院甲状腺疾病诊治中心,云南 昆明 650032 |
|
Risk probability model for residual metastatic lymph node in patients with papillary thyroid microcarcinoma undergoing cervical central lymph node dissection |
LIU Wen,DONG Zhizhong,SU Yanjun,MA Yunhai,ZHANG Jianming,DIAO Chang,QIAN Jun,CHENG Ruochuan( ) |
Thyroid Disease Diagnosis and Treatment Center, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, China |
引用本文:
刘文,董治中,苏艳军,马云海,张建明,刁畅,钱军,程若川. 甲状腺微小乳头状癌患者颈部中央淋巴结清扫术后假阴性风险概率的评估[J]. 浙江大学学报(医学版), 2021, 50(6): 722-729.
LIU Wen,DONG Zhizhong,SU Yanjun,MA Yunhai,ZHANG Jianming,DIAO Chang,QIAN Jun,CHENG Ruochuan. Risk probability model for residual metastatic lymph node in patients with papillary thyroid microcarcinoma undergoing cervical central lymph node dissection. J Zhejiang Univ (Med Sci), 2021, 50(6): 722-729.
链接本文:
https://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2021-0289
或
https://www.zjujournals.com/med/CN/Y2021/V50/I6/722
|
1 |
International Agency for Research on Cancer. Estimated age-standardized incidence rates (World) in 2020, all cancers, both sexes, all ages[DB/OL]. [2021-11-20]. https://gco.iarc.fr/today/online-analysis-map
|
2 |
刘 文, 程若川, 苏艳军, 等. 甲状腺乳头状癌中央区淋巴结转移危险因素研究(附3273例回顾性分析)[J]. 中国实用外科杂志, 2018, 38(3): 75-80 LIU Wen, CHENG Ruochuan, SU Yanjun, et al. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: a single-center retrospective analysis of 3273 cases[J]. Chinese Journal of Practical Surgery, 2018, 38(3): 75-80. (in Chinese)
|
3 |
刘 文, 程若川, 苏艳军, 等. 2015版美国甲状腺协会指南cN0甲状腺乳头状癌手术方案合理性分析[J]. 中国实用外科杂志, 2017, 37(5): 568-571, 576 LIU Wen, CHENG Ruochuan, SU Yanjun, et al. Surgical planning and rational analysis of cN0 papillary thyroid carcinoma for 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J]. Chinese Journal of Practical Surgery, 2017, 37(5): 568-571, 576. (in Chinese)
|
4 |
HAUGENB R, ALEXANDERE K, BIBLEK C, et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]Thyroid, 2016, 26( 1): 1-133.
doi: 10.1089/thy.2015.0020
|
5 |
SUGITANII, ITOY, TAKEUCHID, et al.Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma[J]Thyroid, 2021, 31( 2): 183-192.
doi: 10.1089/thy.2020.0330
|
6 |
中国抗癌协会甲状腺癌专业委员会. 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J]. 中国肿瘤临床, 2016, 43(10): 405-411 Chinese Association of Thyroid Oncology. 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma[J]. Chinese Journal of Clinical Oncology, 2016, 43(10): 405-411. (in Chinese)
|
7 |
LIUW, YANX, CHENGR. The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?[J]Cancer Biol Med, 2021, online.
doi: 10.20892/j.issn.2095-3941.2021.0058
|
8 |
FILETTIS, DURANTEC, HARTLD, et al.Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]Ann Oncol, 2019, 30( 12): 1856-1883.
doi: 10.1093/annonc/mdz400
|
9 |
TAKAMIH, ITOY, OKAMOTOT, et al.Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma[J]World J Surg, 2014, 38( 8): 2002-2010.
doi: 10.1007/s00268-014-2498-y
|
10 |
CHOIJ B, LEEW K, LEES G, et al.Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients[J]Cancer Manag Res, 2018, 2883-2891.
doi: 10.2147/CMAR.S173853
|
11 |
WANGY, GUANQ, XIANGJ. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study of 8668 patients[J]Int J Surg, 2018, 98-102.
doi: 10.1016/j.ijsu.2018.05.023
|
12 |
OHH S, PARKS, KIMM, et al.Young age and male sex are predictors of large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinomas[J]Thyroid, 2017, 27( 10): 1285-1290.
doi: 10.1089/thy.2017.0250
|
13 |
ITOY, URUNOT, NAKANOK, et al.An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid[J]Thyroid, 2003, 13( 4): 381-387.
doi: 10.1089/105072503321669875
|
14 |
MEHANNAH, AL-MAQBILIT, CARTERB, et al.Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up[J]J Clin Endocrinol Metab, 2014, 99( 8): 2834-2843.
doi: 10.1210/jc.2013-2118
|
15 |
刘 文, 闫雪晶, 程若川, 等. 术前临床及超声检查特征对甲状腺乳头状癌中央区淋巴结转移预测价值研究[J]. 中国实用外科杂志, 2020, 40(10): 1197-1201 LIU Wen, YAN Xuejing, CHENG Ruochuan, et al. Predictive central lymph node metastasis on the basis of preoperative features of clinic and ultrasonography in patients with papillary thyroid carcinoma[J]. Chinese Journal of Practical Surgery, 2020, 40(10): 1197-1201. (in Chinese)
|
16 |
程若川, 刘 文. 中国甲状腺癌术后随访和临床研究现状反思[J].中国普通外科杂志, 2017, 26(11): 1375-1382 CHENG Ruochuan, LIU Wen. Reflections on current problems in postoperative follow-up and clinical study of thyroid carcinoma in China[J]. Chinese Journal of General Surgery, 2017, 26(11): 1375-1382. (in Chinese)
|
17 |
CARLINGT, CARTYS E, CIARLEGLIOM M, et al.American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma[J]Thyroid, 2012, 22( 3): 237-244.
doi: 10.1089/thy.2011.0317
|
18 |
CARTYS E, COOPERD S, DOHERTYG M, et al.Consensus statement on the terminology and classification of central neck dissection for thyroid cancer[J]Thyroid, 2009, 19( 11): 1153-1158.
doi: 10.1089/thy.2009.0159
|
19 |
KANDILE, NOURELDINES I, ABBASA, et al.The impact of surgical volume on patient outcomes following thyroid surgery[J]Surgery, 2013, 154( 6): 1346-1353.
doi: 10.1016/j.surg.2013.04.068
|
20 |
G?NENM, SCHRAGD, WEISERM R. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer[J]J Clin Oncol, 2009, 27( 36): 6166-6171.
doi: 10.1200/JCO.2009.23.7958
|
21 |
LIMH, DEVESAS S, SOSAJ A, et al.Trends in thyroid cancer incidence and mortality in the United States, 1974-2013[J]JAMA, 2017, 317( 13): 1338.
doi: 10.1001/jama.2017.2719
|
22 |
RANDOLPHG W, DUHQ Y, HELLERK S, et al.The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension[J]Thyroid, 2012, 22( 11): 1144-1152.
doi: 10.1089/thy.2012.0043
|
23 |
LEEJ, SONGY, SOHE Y. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence[J]World J Surg, 2014, 38( 4): 858-862.
doi: 10.1007/s00268-013-2345-6
|
24 |
中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版)[J/CD]. 中华普通外科学文献(电子版), 2019, 13(1): 1-15 National Health Commission of the People’s Republic of China. Guidelines for diagnosis and treatment of thyroid cancer (2018 edition) [J/CD]. Chinese Archives of General Surgery (Electronic Edition), 2019, 13(1): 1-15. (in Chinese)
|
25 |
LEED H, KIMY K, YUH W, et al.Computed tomography for detecting cervical lymph node metastasis in patients who have papillary thyroid microcarcinoma with tumor characteristics appropriate for active surveillance[J]Thyroid, 2019, 29( 11): 1653-1659.
doi: 10.1089/thy.2019.0100
|
26 |
COOPERD S, DOHERTYG M, HAUGENB R, et al.Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]Thyroid, 2009, 19( 11): 1167-1214.
doi: 10.1089/thy.2009.0110
|
27 |
NOELJ E, ORLOFFL A. Recognizing persistent disease in well-differentiated thyroid cancer and association with lymph node yield and ratio[J]Otolaryngol Head Neck Surg, 2020, 162( 1): 50-55.
doi: 10.1177/0194599819886123
|
28 |
VAS NUNESJ H, CLARKJ R, GAOK, et al.Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma[J]Thyroid, 2013, 23( 7): 811-816.
doi: 10.1089/thy.2012.0460
|
29 |
BEALS H, CHENS L, SCHNEIDERP D, et al.An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma[J]Am Surgeon, 2010, 76( 1): 28-32.
doi: 10.1177/000313481007600107
|
30 |
ROBINSONT J, THOMASS, DINANM A, et al.How many lymph nodes are enough? Assessing the adequacy of lymph node yield for papillary thyroid cancer[J]J Clin Oncol, 2016, 34( 28): 3434-3439.
doi: 10.1200/JCO.2016.67.6437
|
31 |
DONANGELOI, WALTSA E, BRESEEC, et al.Lymphocytic thyroiditis is associated with increased number of benign cervical nodes and fewer central neck compartment metastatic lymph nodes in patients with differentiated thyroid cancer[J]Endocrine Pract, 2016, 22( 10): 1192-1198.
doi: 10.4158/E151078.OR
|
32 |
LAIV, YENT W F, ROSEB T, et al.The effect of thyroiditis on the yield of central compartment lymph nodes in patients with papillary thyroid cancer[J]Ann Surg Oncol, 2015, 22( 13): 4181-4186.
doi: 10.1245/s10434-015-4551-y
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|